Pegvisomant: a new treatment modality for acromegaly.

Acromegaly, a multisystemic disease resulting from excessive growth hormone (GH) and insulin-like growth factor-I (IGF-I) levels in adults, is associated with a two-to-threefold increase in mortality. The available treatment options (surgery, radiotherapy and medical treatment with somatostatin anal...

Full description

Bibliographic Details
Main Authors: Karavitaki, N, Wass, J
Format: Journal article
Language:English
Published: 2004